The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gonadotropin-releasing Hormone Agonist Drugs Market Research Report 2025
Synopsis
Gonadotropin-releasing Hormone is a releasing hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary.
The global Gonadotropin-releasing Hormone Agonist Drugs market was valued at US$ 4152 million in 2023 and is anticipated to reach US$ 4576.3 million by 2030, witnessing a CAGR of 1.3% during the forecast period 2024-2030.
The Luteinizing Hormone-releasing Hormone (LHRH) Analogs market is primarily driven by the demand for hormone therapy options in managing hormone-dependent conditions such as prostate cancer and certain gynecological disorders. LHRH analogs, also known as LHRH agonists, are medications that suppress the release of sex hormones by altering the signaling of the hypothalamus-pituitary-gonadal axis. The increasing prevalence of hormone-related diseases, coupled with advancements in oncology and reproductive medicine, contributes to market growth. Moreover, the demonstrated benefits of LHRH analogs in reducing hormone levels and controlling tumor growth further propel adoption. However, challenges include optimizing treatment regimens for specific conditions and addressing potential side effects such as hormonal imbalances and bone density loss. Navigating personalized treatment plans, managing patient expectations, and ensuring long-term safety and efficacy are ongoing concerns. The market's success relies on continuous research in endocrinology and oncology, collaborations between pharmaceutical manufacturers and healthcare providers, and comprehensive patient education on the benefits and potential risks of LHRH analog treatments while addressing the evolving challenges associated with hormone-related diseases and treatment customization.
This report aims to provide a comprehensive presentation of the global market for Gonadotropin-releasing Hormone Agonist Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gonadotropin-releasing Hormone Agonist Drugs.
Report Scope
The Gonadotropin-releasing Hormone Agonist Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gonadotropin-releasing Hormone Agonist Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gonadotropin-releasing Hormone Agonist Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
AstraZeneca
Ferring
TerSera Therapeutics
Takeda
LIVZON
Ipsen
Sanofi
Endo
Segment by Type
Leuprorelin
Goserelin
Taltirelin
Histrelin
Other
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gonadotropin-releasing Hormone Agonist Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gonadotropin-releasing Hormone Agonist Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Gonadotropin-releasing Hormone is a releasing hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary.
The global Gonadotropin-releasing Hormone Agonist Drugs market was valued at US$ 4152 million in 2023 and is anticipated to reach US$ 4576.3 million by 2030, witnessing a CAGR of 1.3% during the forecast period 2024-2030.
The Luteinizing Hormone-releasing Hormone (LHRH) Analogs market is primarily driven by the demand for hormone therapy options in managing hormone-dependent conditions such as prostate cancer and certain gynecological disorders. LHRH analogs, also known as LHRH agonists, are medications that suppress the release of sex hormones by altering the signaling of the hypothalamus-pituitary-gonadal axis. The increasing prevalence of hormone-related diseases, coupled with advancements in oncology and reproductive medicine, contributes to market growth. Moreover, the demonstrated benefits of LHRH analogs in reducing hormone levels and controlling tumor growth further propel adoption. However, challenges include optimizing treatment regimens for specific conditions and addressing potential side effects such as hormonal imbalances and bone density loss. Navigating personalized treatment plans, managing patient expectations, and ensuring long-term safety and efficacy are ongoing concerns. The market's success relies on continuous research in endocrinology and oncology, collaborations between pharmaceutical manufacturers and healthcare providers, and comprehensive patient education on the benefits and potential risks of LHRH analog treatments while addressing the evolving challenges associated with hormone-related diseases and treatment customization.
This report aims to provide a comprehensive presentation of the global market for Gonadotropin-releasing Hormone Agonist Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gonadotropin-releasing Hormone Agonist Drugs.
Report Scope
The Gonadotropin-releasing Hormone Agonist Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gonadotropin-releasing Hormone Agonist Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gonadotropin-releasing Hormone Agonist Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
AstraZeneca
Ferring
TerSera Therapeutics
Takeda
LIVZON
Ipsen
Sanofi
Endo
Segment by Type
Leuprorelin
Goserelin
Taltirelin
Histrelin
Other
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gonadotropin-releasing Hormone Agonist Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gonadotropin-releasing Hormone Agonist Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Gonadotropin-releasing Hormone Agonist Drugs Market Overview
1.1 Product Overview and Scope of Gonadotropin-releasing Hormone Agonist Drugs
1.2 Gonadotropin-releasing Hormone Agonist Drugs Segment by Type
1.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Leuprorelin
1.2.3 Goserelin
1.2.4 Taltirelin
1.2.5 Histrelin
1.2.6 Other
1.3 Gonadotropin-releasing Hormone Agonist Drugs Segment by Application
1.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size Estimates and Forecasts
1.4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue 2019-2030
1.4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales 2019-2030
1.4.3 Global Gonadotropin-releasing Hormone Agonist Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gonadotropin-releasing Hormone Agonist Drugs Market Competition by Manufacturers
2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Gonadotropin-releasing Hormone Agonist Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, Product Type & Application
2.7 Gonadotropin-releasing Hormone Agonist Drugs Market Competitive Situation and Trends
2.7.1 Gonadotropin-releasing Hormone Agonist Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gonadotropin-releasing Hormone Agonist Drugs Players Market Share by Revenue
2.7.3 Global Gonadotropin-releasing Hormone Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gonadotropin-releasing Hormone Agonist Drugs Retrospective Market Scenario by Region
3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region: 2019-2030
3.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region: 2019-2024
3.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region: 2025-2030
3.3 Global Gonadotropin-releasing Hormone Agonist Drugs Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region: 2019-2030
3.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region: 2019-2024
3.3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region: 2025-2030
3.4 North America Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.4.1 North America Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2019-2030)
3.4.3 North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.5.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2019-2030)
3.5.3 Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.7.1 Latin America Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2019-2030)
3.7.3 Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2019-2030)
4.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2019-2024)
4.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2025-2030)
4.1.3 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2019-2030)
4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2019-2030)
4.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2019-2024)
4.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2025-2030)
4.2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2019-2030)
5.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2019-2024)
5.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2025-2030)
5.1.3 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2019-2030)
5.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application (2019-2030)
5.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application (2019-2024)
5.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application (2025-2030)
5.2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Ferring
6.3.1 Ferring Corporation Information
6.3.2 Ferring Description and Business Overview
6.3.3 Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ferring Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.3.5 Ferring Recent Developments/Updates
6.4 TerSera Therapeutics
6.4.1 TerSera Therapeutics Corporation Information
6.4.2 TerSera Therapeutics Description and Business Overview
6.4.3 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.4.5 TerSera Therapeutics Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Takeda Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 LIVZON
6.6.1 LIVZON Corporation Information
6.6.2 LIVZON Description and Business Overview
6.6.3 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.6.5 LIVZON Recent Developments/Updates
6.7 Ipsen
6.6.1 Ipsen Corporation Information
6.6.2 Ipsen Description and Business Overview
6.6.3 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.7.5 Ipsen Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Endo
6.9.1 Endo Corporation Information
6.9.2 Endo Description and Business Overview
6.9.3 Endo Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Endo Gonadotropin-releasing Hormone Agonist Drugs Product Portfolio
6.9.5 Endo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gonadotropin-releasing Hormone Agonist Drugs Industry Chain Analysis
7.2 Gonadotropin-releasing Hormone Agonist Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gonadotropin-releasing Hormone Agonist Drugs Production Mode & Process
7.4 Gonadotropin-releasing Hormone Agonist Drugs Sales and Marketing
7.4.1 Gonadotropin-releasing Hormone Agonist Drugs Sales Channels
7.4.2 Gonadotropin-releasing Hormone Agonist Drugs Distributors
7.5 Gonadotropin-releasing Hormone Agonist Drugs Customers
8 Gonadotropin-releasing Hormone Agonist Drugs Market Dynamics
8.1 Gonadotropin-releasing Hormone Agonist Drugs Industry Trends
8.2 Gonadotropin-releasing Hormone Agonist Drugs Market Drivers
8.3 Gonadotropin-releasing Hormone Agonist Drugs Market Challenges
8.4 Gonadotropin-releasing Hormone Agonist Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Gonadotropin-releasing Hormone Agonist Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gonadotropin-releasing Hormone Agonist Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gonadotropin-releasing Hormone Agonist Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gonadotropin-releasing Hormone Agonist Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gonadotropin-releasing Hormone Agonist Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gonadotropin-releasing Hormone Agonist Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonadotropin-releasing Hormone Agonist Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Type (2019-2024)
Table 59. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Type (2025-2030)
Table 60. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Application (2019-2024)
Table 69. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Application (2025-2030)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Product
Table 74. AbbVie Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Ferring Corporation Information
Table 81. Ferring Description and Business Overview
Table 82. Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Ferring Gonadotropin-releasing Hormone Agonist Drugs Product
Table 84. Ferring Recent Developments/Updates
Table 85. TerSera Therapeutics Corporation Information
Table 86. TerSera Therapeutics Description and Business Overview
Table 87. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Product
Table 89. TerSera Therapeutics Recent Developments/Updates
Table 90. Takeda Corporation Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Takeda Gonadotropin-releasing Hormone Agonist Drugs Product
Table 94. Takeda Recent Developments/Updates
Table 95. LIVZON Corporation Information
Table 96. LIVZON Description and Business Overview
Table 97. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Product
Table 99. LIVZON Recent Developments/Updates
Table 100. Ipsen Corporation Information
Table 101. Ipsen Description and Business Overview
Table 102. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Product
Table 104. Ipsen Recent Developments/Updates
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Endo Corporation Information
Table 111. Endo Description and Business Overview
Table 112. Endo Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Endo Gonadotropin-releasing Hormone Agonist Drugs Product
Table 114. Endo Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Gonadotropin-releasing Hormone Agonist Drugs Distributors List
Table 118. Gonadotropin-releasing Hormone Agonist Drugs Customers List
Table 119. Gonadotropin-releasing Hormone Agonist Drugs Market Trends
Table 120. Gonadotropin-releasing Hormone Agonist Drugs Market Drivers
Table 121. Gonadotropin-releasing Hormone Agonist Drugs Market Challenges
Table 122. Gonadotropin-releasing Hormone Agonist Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gonadotropin-releasing Hormone Agonist Drugs
Figure 2. Global Gonadotropin-releasing Hormone Agonist Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gonadotropin-releasing Hormone Agonist Drugs Market Share by Type in 2023 & 2030
Figure 4. Leuprorelin Product Picture
Figure 5. Goserelin Product Picture
Figure 6. Taltirelin Product Picture
Figure 7. Histrelin Product Picture
Figure 8. Other Product Picture
Figure 9. Global Gonadotropin-releasing Hormone Agonist Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Gonadotropin-releasing Hormone Agonist Drugs Market Share by Application in 2023 & 2030
Figure 11. Hospital
Figure 12. Pharmacy
Figure 13. Other
Figure 14. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Gonadotropin-releasing Hormone Agonist Drugs Market Size (2019-2030) & (US$ Million)
Figure 16. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (2019-2030) & (K Units)
Figure 17. Global Gonadotropin-releasing Hormone Agonist Drugs Average Price (USD/Unit) & (2019-2030)
Figure 18. Gonadotropin-releasing Hormone Agonist Drugs Report Years Considered
Figure 19. Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Manufacturers in 2023
Figure 20. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Gonadotropin-releasing Hormone Agonist Drugs Players: Market Share by Revenue in 2023
Figure 22. Gonadotropin-releasing Hormone Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2019-2030)
Figure 25. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2019-2030)
Figure 26. United States Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2019-2030)
Figure 29. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2019-2030)
Figure 30. Germany Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2019-2030)
Figure 37. China Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2019-2030)
Figure 47. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Type (2019-2030)
Figure 57. Global Revenue Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Type (2019-2030)
Figure 58. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Application (2019-2030)
Figure 60. Global Revenue Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Application (2019-2030)
Figure 61. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Application (2019-2030)
Figure 62. Gonadotropin-releasing Hormone Agonist Drugs Value Chain
Figure 63. Gonadotropin-releasing Hormone Agonist Drugs Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
